Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

Licence status
Authorised: 23/08/2023
Active substances
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B
Dosage Form
Powder and solvent for solution for injection
Licence number
EU/1/23/1752/001-006
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
J07BX05 respiratory syncytial virus vaccines
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/08/2023